drugset / Trial / NCT02617459

Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension

NCT02617459

RandomizedParallel-groupSingle-blindTreatment

Summary

To evaluate the safety and efficacy of Levobetaxolol in Chinese patients with glaucoma.

Timeline

Start
2019-01-04
Primary completion
2021-07-01
Completion
2021-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobetaxolol Small molecule Other
Comparator betaxolol Small molecule Other